The law of written description in pharmaceutical and biotechnology patents

被引：1

作者：

Manak, JM ^{[1
]}

机构：

[1] Greenberg Traurig LLP, New York, NY USA

来源：

BIOTECHNOLOGY LAW REPORT | 2004年 / 23卷 / 01期

关键词：

D O I：

10.1089/073003104322838231

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

[No abstract available]

引用

页码：30 / 47

页数：18

共 50 条

[1] Amgen v. Hoechst Marion Roussel: The written description standard in biotechnology patents
Behringer, J
Wu, M
Chen, HY
[J]. BIOTECHNOLOGY LAW REPORT, 2003, 22 (05) : 476 - 480
[2] FUTURE OF EUROPEAN BIOTECHNOLOGY PATENTS LAW
ROGERS, A
[J]. LANCET, 1994, 343 (8907): : 1220 - 1220
[3] Written description of chemical and pharmaceutical inventions
Cauble, David
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 252
[4] Biotechnology patents in Europe: from law to ethics
Van Overwalle, G
[J]. BIOTECHNOLOGY, PATENTS AND MORALITY, 1997, : 139 - 148
[5] Pharmaceutical medicine, biotechnology and European law
Malinowski, MJ
[J]. JOURNAL OF LEGAL MEDICINE, 2002, 23 (01) : 159 - 166
[6] Patent prosecution of biotechnology and pharmaceutical patents in a changing legal landscape
Lu, Deborah L.
Kowalski, Thomas J.
Jarecki-Black, Judy
[J]. FUTURE MEDICINAL CHEMISTRY, 2010, 2 (01) : 7 - 9
[7] The New Law Governing Pharmaceutical patents in Mexico
Rangel-Ortiz, H
[J]. IIC-INTERNATIONAL REVIEW OF INTELLECTUAL PROPERTY AND COMPETITION LAW, 2005, 36 (04) : 434 - 445
[8] Battling the written description requirement of patents in prosecution and litigation.
Kjelland, KM
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 227 : U705 - U705
[9] Scientific foundation, patents, and new product introductions of biotechnology and pharmaceutical firms
Watts, Allison D.
Hamilton, Robert D., III
[J]. R & D MANAGEMENT, 2013, 43 (05) : 433 - 446
[10] Biotechnology and patents
Straus, J
[J]. CHIMIA, 2000, 54 (05) : 293 - 298

← 1 2 3 4 5 →